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COVID-19 disease is caused by the SARS-CoV-2 virus (a new coronavirus)
that emerged in China in December 2019. Disease symptoms at the time of
diagnosis vary from those who have the infection but suffer no ill effects or
have minor illness to those requiring breathing and intensive care support.
Severe disease is more common with increasing age, particularly from 65
years and over.
COVID-19 vaccine in pregnancy
There is no known risk with giving inactivated virus or bacterial vaccines or
toxoids during pregnancy or whilst breast-feeding. However, the COVID-19
vaccines have not yet been tested in pregnancy, so it has been advised that
until more information is available, pregnant women should not routinely
have these vaccines. As a matter of caution, COVID-19 vaccine is therefore
not routinely advised in pregnancy but there are some circumstances in
which the potential benefits of vaccination are particularly important for
pregnant women. This may include women who are at very high risk of
catching the infection or those with certain medical conditions that put
them at high risk of suffering serious complications from COVID-19 infection.
In such circumstances, a woman may choose to have COVID-19 vaccine in
pregnancy following a discussion with her doctor or nurse.
If a COVID-19 vaccine is given to a pregnant woman, she should be reassured
that the vaccine does not contain live SARS-CoV-2 virus and therefore
cannot cause COVID-19 infection in her or in her baby. Some COVID-19
vaccines contain a different harmless virus to help deliver the vaccine –
whilst this virus is live, it cannot reproduce and so will not cause infection in
a pregnant woman or her baby.
Evidence so far reviewed by the Medicines and Healthcare products
Regulatory Agency (MHRA), the UK regulatory agency responsible for
licencing medicines including vaccines, has raised no concerns for safety in
pregnancy.
The data for each licensed COVID-19 vaccine in pregnancy is limited because
pregnant women are not included in vaccine trials. This is not because of any
specific safety concerns but as a matter of caution, like that applied to trials
of most other medicines.
If a woman finds out she is pregnant after she has started a course of
vaccine, she should complete her pregnancy before finishing the
recommended schedule.
COVID-19 disease in pregnancy
Available evidence suggests that COVID-19 infection in pregnancy is unlikely
to lead to problems with a baby’s development and there have not been any
reports of this. There is also no evidence of an increased risk of miscarriage if
you become infected during pregnancy.
There is some evidence that babies can be born prematurely to women who
are very unwell with coronavirus[footnote 1]. In a UK study of pregnant women
with COVID-19 disease serious enough to require hospital admission (most
infected in the second or third trimester), only 6 of 265 babies tested
positive for COVID-19 immediately after birth. In line with other studies, this
suggests it is uncommon for the natural infection to pass from a woman to
her baby. When babies have developed COVID-19 soon after birth they have
been well.
The UK Vaccine in Pregnancy
surveillance programme
All COVID-19 vaccines given from the first day of last menstrual period to any
time in pregnancy should be reported to the UK Vaccine in Pregnancy
surveillance programme run by the Immunisation Department of Public
Health England.
The objectives of the UK vaccine in pregnancy surveillance are to compile
additional information on women who are immunised with specified vaccines
whilst pregnant to monitor the safety of such exposures. This data will be
used to help better inform pregnant women who are immunised, their
families and health professionals who are responsible for their care.
This surveillance is being undertaken in collaboration with the MHRA, the
UK teratology information service (UKtis) and with Public Health Scotland,
Public Health Wales and Public Health Agency in Northern Ireland.
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